title: [Analysis of the circadian rhythm of motor activity in white rats by using several pharmacologic agents which act on cerebral monoamines].
abstract: Three pharmacological agents, (disulfiram, imipramine and reserpine) influencing the brain monoamine transmitters have been studied to explain the mechanism involved in the motor circadian rhythm. The new results corroborate our previous ones : the norepinephrine transmitter responsible for the paradoxical sleep is unable to explain the depressed metabolic phase of the circadian rhythm; the negative results obtained with disulfiram and imipramine corroborate the previous results with nialamide. On the contrary, the agents which reduce the serotonine transmitter mechanisms (p-chlorophenylalanine) decrease the difference between active and sleep phases by their action involved in the non-activated sleep. Reserpine, supposed to reduce both transmitter mechanisms (serotonine and norepinephrine) shows a p-chlorophenylalanine-like effect, perhaps more strong. It thus appears that the non-activated sleep is responsible for the two essential sleep functions : the restitution function and the depressed phase of the circadian rhythm.
mesh_terms: D000818:Animals; D001921:Brain / Q000187:drug effects / Q000502:physiology*; D002940:Circadian Rhythm / Q000187:drug effects; D004221:Disulfiram / Q000494:pharmacology; D010134:Fenclonine / Q000494:pharmacology; D007099:Imipramine / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects / Q000502:physiology*; D009526:Nialamide / Q000494:pharmacology; D009638:Norepinephrine / Q000502:physiology; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D012701:Serotonin / Q000502:physiology; D012894:Sleep Stages / Q000187:drug effects / Q000502:physiology
chemical_list: D012701:Serotonin; D012110:Reserpine; D007099:Imipramine; D010134:Fenclonine; D009526:Nialamide; D004221:Disulfiram; D009638:Norepinephrine
vernacular_title: Analyse du rythme circadien de l'activité motrice du rat blanc par l'emploi de plusieurs agents pharmacologiques agissant sur les monoamines cérébrales.